Long‐term outcome of chronic myeloid leukaemia patients with p210 and p190 co‐expression at baseline

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|169|1|148-150

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.169, Iss.1, 2015-04, pp. : 148-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Philadelphia-Positive Chronic-Phase Chronic Myeloid Leukaemia after Long-Term Remission of Philadelphia-Negative Acute Lymphoblastic Leukaemia

By  

Acta Haematologica, Vol. 119, Iss. 2, 2008-04 ,pp. : 124-125

Karger

Access to resources Recommend Favorite

Long‐term results of high‐dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 398-407

John Wiley & Sons Inc

Access to resources Recommend Favorite

LONG‐TERM OUTCOME OF MINDFULNESS‐BASED COGNITIVE THERAPY IN RECURRENTLY DEPRESSED PATIENTS WITH AND WITHOUT A DEPRESSIVE EPISODE AT BASELINE

By  

DEPRESSION AND ANXIETY (ELECTRONIC), Vol. 32, Iss. 8, 2015-08 ,pp. : 563-569

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease

By  

Acta Haematologica, Vol. 135, Iss. 3, 2015-11 ,pp. : 133-139

Karger

Access to resources Recommend Favorite

Long‐term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 57, Iss. 3, 2018-03 ,pp. : 332-338

John Wiley & Sons Inc

Access to resources Recommend Favorite